[ad_1]
Probenecid, an FDA-approved gout treatment with “potent antiviral properties” and minimal side effects, is “a prime candidate” for the treatment of COVID-19 according to a new study.
SciTechDaily reports recent research from the University of Georgia, where they found that probenecid “works as a prophylactic before exposure to the virus and as a post-exposure treatment in animal models for SARS-CoV-2 and influenza” .
Ralph Tripp, lead author of the study, concluded: “This antiviral works for all respiratory RNA viruses that we have tested, including SARS-CoV-2. RSV, coronavirus, and influenza all circulate in the same season. Ultimately, you can potentially reduce infections and illnesses by using this oral medication alone.
This is potentially great news.
COVID-19-related hospitalizations have increased in recent weeks as the delta variant makes its way into the population. Even though the Delta is much less deadly than the initial version of the Wuhan flu, no one wants to be stuck in a hospital or on a ventilator.
Tripp’s company, TrippBio, is expected to begin clinical trials of probenecid against COVID later this year.
Recommended: Biden White House knows the vaccination warrant is illegal. Here is the proof.
Although I wish they would hurry.
Floridians and Texans have already gotten through the worst of the delta peak, but the seasonality means it’s heading north for winter.
The wave is about to increase northward. It decreases in the south.
As winter and the interior arrive for the north, so will COVID.
As summer and air conditioning leave the south, so will COVID.
Lesson: Keep your windows open.
Plus, your moral smoothing doesn’t affect COVID.
– Melissa Mackenzie (@MelissaTweets) September 10, 2021
As I have already noted, the delta is far from the health risk posed by the original strain. However, this remains a huge political risk.
You’ve probably noticed in the last few months that Washington and the mainstream media (but I’m repeating myself) have moved the goalposts.
Many times.
“Two weeks to flatten the curve” was to prevent our intensive care units from being overloaded and, at worst, causing a collapse of civil society.
Once the curve was flattened, the restrictions were maintained until we could get a vaccine.
Once we got the vaccines, plural, the restrictions were still in place until 70% of the population could be vaccinated.
Then 80%.
Then we were told that 90% would not even be high enough.
But it has become increasingly difficult, politically, to keep Americans under pressure as COVID becomes less deadly.
So, the last measure for our national panics is the “case”.
Recommended: The dirty little secret about Biden’s vaccination mandate that no one wants to talk about
Not the dead. Not even hospitalizations. But simple cases for a flu-like virus which is becoming less and less fatal day by day.
Given how infectious the Delta is, “cases” are a big excuse for little things like the tyranny of vaccination warrants and a virtual social credit system to travel freely around the country.
But “case” is a lousy metric for a bug that most bugs will get, but few will actually suffer. The “cases” are only a good measure for those who seek to impose more and more social and economic controls on a once free people.
If the probenecid study is successful and the drug really has both treatment and prophylactic effects against various Wuhan bugs, so it’s not just a weapon against a virus.
Probenecid could very well prove to be a powerful political weapon against Washington’s growing predations on our freedoms.
Hell, it might even cause a few Karen to shut up and disguise themselves for a change.
I don’t put too much hope on the last point, mind you.
The policy of COVID has proven to be much more damaging – and ultimately, possibly much more deadly, too – than COVID itself.
We need every arrows we can get from our quiver to strike back, so here’s the probenecid that turns out to be another.
One more thing.
Items like this are exclusively for our VIPs. Not just because you’re worth it, but because Facebook, Google, and Twitter won’t let us share COVID stories about probenecid, ivermectin, or anything else that doesn’t match their narrative.
But like any other business, PJ Media must grow in order to survive.
So why not share this report with a few friends or family, along with a link to our subscription page?
We would certainly love to have them on board too, and to broaden the audience to real new.
[ad_2]
Source link